← FDA Drug Approvals (Drugs@FDA)
ZAFIRLUKAST
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2023-11-27
Drug application
- FDA Application #
ANDA213163- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ZAFIRLUKAST
- Generic name
- ZAFIRLUKAST
- Active ingredients
- ZAFIRLUKAST
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2023-11-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown